ADVERTISE HERE 

DrugPatentWatch Information on Approved Drugs and Drug Products

This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Want more information? Subscribe to the complete database

Ultimate PlanPremium PlanBasic Plan
One year$1,895 Subscribe$1,695 Subscribe$975 Subscribe
One month$475 Subscribe$375 Subscribe$275 Subscribe
Plan comparison    Site tour

Drug Patent Expirations for March 2010

TradenameApplicantGeneric NamePatent Number Patent Expiration
AZASITEInspireazithromycin5,192,535Mar 9, 2010
SOLAGEStiefel Labs Incmequinol; tretinoin5,470,567Mar 19, 2010
PYLERAAxcan Scandipharmbismuth subcitrate potassium; metronidazole; tetracycline5,476,669Mar 23, 2010
KADIANActavis Elizabethmorphine sulfate5,378,474Mar 23, 2010
PYLERAAxcan Scandipharmbismuth subcitrate potassium; metronidazole; tetracycline5,196,205Mar 23, 2010
EMBEDAAlpharma Kingmorphine sulfate; naltrexone hydrochloride5,378,474Mar 23, 2010
CADUETPfizeramlodipine besylate; atorvastatin calcium4,681,893*PEDMar 24, 2010
LIPITORPfizeratorvastatin calcium4,681,893*PEDMar 24, 2010
CARDENE SREkr Therapnicardipine hydrochloride5,198,226Mar 30, 2010

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

SUBSCRIPTIONS

If this newsletter has been forwarded to you and you would like to subscribe, go to http://www.DrugPatentWatch.com/newsletter

The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the DrugPatentWatch database for complete details

DISCLAIMER:
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
All trademarks and applicant names are the property of their respective owners or licensors.

[ Home | Site Tour | Free Patent Expiration Newsletter | Pharmaceutical Innovation Dashboard | Affiliate Program | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
[del.icio.us] [Digg] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]
Bookmark & Share

Pharmaceutical industry competitive intellgence